Spain OKs TiGenix's bigger cell therapy plant as firm preps for Cx601
Spain has licensed TiGenix NV's expanded Madrid plant paving the way for a potential European launch of Cx601 its cell therapy forÂthe Crohn's disease complications.
View ArticleOld Crohn's Theory Relevant Now Gastro Endo News Report
MedPage Today Also proton pump inhibitors and pancreatic cancer link
View ArticleSoligenix to Present at the Rodman & Renshaw 19th Annual Global Investment...
PRINCETON N.J. Sept. 7 2017 PRNewswire Soligenix Inc. Nasdaq SNGX Soligenix or the Company a latestage biopharmaceutical company focused on developing and commercializing products to treat rare...
View ArticleAevi Genomic Medicine Inc GNMX Financial and Strategic SWOT Analysis Review...
SummaryAevi Genomic Medicine Inc Aevi formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and lifealtering diseases.The...
View ArticleDeciphera Pharmaceuticals LLC Pharmaceuticals Healthcare Deals and Alliances...
SummaryDeciphera Pharmaceuticals LLC Deciphera Pharmaceuticals is a research and development company that develops designs and commercializes kinase inhibiting drugs. The company's clinical pipeline of...
View ArticleCarcinoembryonic Antigen Related Cell Adhesion Molecule 5 Carcinoembryonic...
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5 Pipeline Review H2 2017SummaryCarcinoembryonic Antigen Related Cell...
View ArticleGalapagos NV GLPG Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryGalapagos NV Galapagos is a biotechnology company that discovers and develops pharmaceutical products. The company's product pipeline encompasses investigational candidates targeted at the...
View ArticleSigmoid Pharma Ltd Pharmaceuticals Healthcare Deals and Alliances Profile...
SummarySigmoid Pharma Ltd Sigmoid formerly known as Sigmoid Biotechnologies Ltd is a specialty pharmaceutical company which develops new therapies for unmet clinical needs in gastrointestinal and...
View ArticleUCB SA UCB Pharmaceuticals Healthcare Deals and Alliances Profile Report...
SummaryUCB SA UCB is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the...
View ArticleTransient Receptor Potential Cation Channel Subfamily V Member 1 Capsaicin...
Transient Receptor Potential Cation Channel Subfamily V Member 1 Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1 Pipeline Review H2 2017SummaryTransient Receptor Potential Cation Channel Subfamily...
View ArticleImmune Pharmaceuticals Inc IMNP Pharmaceuticals Healthcare Deals and...
SummaryImmune Pharmaceuticals Inc Immune Pharma formerly EpiCept Corp is a biotechnology company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and cancer....
View ArticleAsana Medical Inc. to Present as Innovation Challenge Finalist at RESI Boston...
MIAMI LAKES FL Marketwired 091117 Asana Medical Inc. "Asana" the "Company" a regenerative medicine company developing a novel treatment for Ulcerative Colitis is pleased to announce that it has been...
View ArticleGlobal Capsule Endoscopy Market Size Anticipated to Grow at 8.7 CAGR From...
FELTON California September 11 2017 PRNewswire The global Capsule Endoscopy market size was valued at USD 454.7 million in 2014 and is expected to grow at a CAGR of 8.7 in coming years. The market is...
View ArticleBNBuilders Awarded First Project for Sharp HealthCare San Diego CA
SAN DIEGO Sept. 11 2017 PRNewswire BNBuilders is pleased to announce that it has been awarded the $1.5 million Sharp Infusion Therapy Relocation project. As part of the designbuild team with...
View ArticleProtagonist Therapeutics to Present at the Cantor Fitzgerald Global...
MILPITAS Calif. Sept. 11 2017 PRNewswire Protagonist Therapeutics Inc. NASDAQ PTGX today announced that Dinesh V. Patel Ph.D. the Company's President and Chief Executive Officer will provide a...
View ArticleCrohn's & Colitis Foundation Commemorates 50 Years of Leadership Innovation &...
NEW YORK Sept. 12 2017 PRNewswireUSNewswire Since 1967 the Crohn's & Colitis Foundation has been at the forefront of research education support and advocacy for Crohn's disease and ulcerative...
View ArticleGlobal Gastrointestinal Partnering 20102017 Deal trends players and financials
LONDON Sept. 12 2017 PRNewswire Global Gastrointestinal Partnering 2010 to 2017 provides the full collection of Gastrointestinal disease deals signed between the world's pharmaceutical and...
View ArticleThe Efficacy of Probiotics in Inflammatory Bowel Disease
This study examined the efficacy of probiotics in inducing and maintaining remission in ulcerative colitis and Crohn disease as well as preventing relapse in postoperative CD. Alimentary Pharmacology...
View ArticleQueens Medical Associates Shares Insight on Pain for Pain Awareness Month
Queens oncology and hematology center provides tips on finding pain reliefNew York NY PRWEB September 12 2017 In recognition of September as Pain Awareness Month Gabriel H. Jung M.D....
View ArticleNovartis Cosentyx sets the new benchmark in psoriasis with robust 5year...
EAST HANOVER N.J. Sept. 13 2017 PRNewswire Novartis announced today first of its kind Phase III data showing Cosentyx secukinumab delivered high and longlasting skin clearance in patients with...
View Article